LegalZoom Reports Strong 2025 Results, Positive 2026 Outlook, and Boosts Share Buyback by $100M
LZ is trading near its 52-week low of $6.47 (8.2% above the low) on elevated volume (1.9× avg).
Summary
LegalZoom announced robust full-year 2025 financial results, provided optimistic 2026 guidance, and significantly increased its stock repurchase program by $100 million, signaling strong confidence in future performance and commitment to shareholder returns.
Key Events · Earnings and Guidance · LZ
-
Strong Full-Year 2025 Performance
Achieved $756.0 million in revenue, up 11% year-over-year, with subscription revenue growing 13% and Adjusted EBITDA increasing 16% to $172.2 million.
-
Positive 2026 Financial Guidance
Forecasts full-year 2026 revenue between $805 million and $825 million (8% YOY growth at midpoint) and Adjusted EBITDA between $190 million and $200 million (13% YOY growth at midpoint).
-
Significant Share Repurchase Increase
The Board approved a $100.0 million increase to the existing stock repurchase program, demonstrating confidence in the company's valuation and commitment to returning capital to shareholders.
-
Robust Cash Generation
Reported record full-year operating cash flow of $178.2 million, up 31% year-over-year, and record free cash flow of $147.9 million, up 48% year-over-year, with $203.1 million in cash and no debt.
Analysis · LZ · Technology
LegalZoom's 8-K filing reveals a strong financial position and an optimistic outlook, driven by solid revenue growth, particularly in subscriptions, and expanding Adjusted EBITDA. The significant $100 million increase to the share repurchase program underscores management's confidence in the company's intrinsic value and its commitment to enhancing shareholder returns. While GAAP net income saw a decline, the robust cash flow generation and positive 2026 guidance, coupled with a healthy balance sheet (no debt), suggest a strong operational foundation. Investors should view this as a positive signal regarding the company's strategic direction and financial health.
At the time of this filing, LZ was trading at $7.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $6.47 to $12.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.